Compugen Stock

Compugen Short-term Debt

Delisted·Jun 15, 2026

The Short-Term Debt of Compugen (CGEN) as of Aug 3, 2026 is 521,000.00 USD. In the previous year, Short-Term Debt was 448,000.00 USD — a change of 16.29% (higher).

Short-term Debt

521,000.00USD

YoY

16.29%

Last updated:

Short-Term Debt of Compugen is 2026 521,000.00 USD. Short-Term Debt of Compugen was 2025 448,000.00 USD. It decreases by 16.29% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Short-Term Debt of Compugen is 521,000.00 USD in 2026.

Short-Term Debt of Compugen changed from 448,000.00 USD to 521,000.00 USD, representing a 16.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Compugen since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Compugen historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Compugen

All Key Metrics — Compugen